首页> 外文期刊>Hepatology research: the official journal of the Japan Society of Hepatology >Diuretics aggravate zinc deficiency in patients with liver cirrhosis by increasing zinc excretion in urine
【24h】

Diuretics aggravate zinc deficiency in patients with liver cirrhosis by increasing zinc excretion in urine

机译:利尿剂通过增加尿中锌的排泄加剧肝硬化患者的锌缺乏

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Liver cirrhosis is often accompanied by zinc deficiency. The exact mechanisms underlying zinc deficiency remain unclear. This study was undertaken to clarify the influence of diuretics on blood zinc levels and zinc excretion in urine in liver cirrhosis. Methods: Seventy-nine outpatients with liver cirrhosis were divided into four groups: (i) patients receiving no zinc preparations or diuretics (LC group); (ii) those receiving zinc preparations only (LCZ group); (iii) those receiving diuretics only (LCD group); and (iv) those receiving both zinc preparations and diuretics (LCDZ group). Among these groups, the effects of the administrated drugs on blood zinc levels and urinary zinc excretion were analyzed. Results: Blood zinc levels were significantly lower in the LCD group (47.8±10.5μg/dL) than in the other groups (LC: 68.8±17.1μg/dL, P=0.0056, post-hoc test; LCZ: 78.4±18.1, P<0.0001; LCDZ: 70.3±21.4, P=0.0008). The creatinine-adjusted urinary zinc excretion was significantly higher in the LCDZ group (548.1±407.6μg/mg creatinine) than in the other groups (LC, 58.5±43.7; LCZ, 208.1±227.8; LCD, 105.2±154.4; each P<0.0001). The fraction of urinary zinc excretion was also significantly higher in the LCDZ group (5.6±2.9%) than in the other groups (LC, 0.6±0.5; LCD, 1.7±1.5; LCZ, 1.6±1.2; each P<0.0001). Conclusion: In patients with liver cirrhosis, treatment with diuretics can increase zinc excretion by suppressing the reabsorption of zinc through renal tubules, which might lead to zinc deficiency.
机译:肝硬化常伴有锌缺乏症。锌缺乏的确切机制尚不清楚。进行这项研究是为了阐明利尿剂对肝硬化患者尿液中锌含量和锌排泄的影响。方法:将79例肝硬化门诊患者分为四组:(i)无锌制剂或利尿剂的患者(LC组); (ii)仅接受锌制剂的人群(LCZ组); (iii)仅接受利尿剂的人(LCD组); (iv)同时接受锌制剂和利尿剂的人(LCDZ集团)。在这些组中,分析了所用药物对血锌水平和尿锌排泄的影响。结果:LCD组的血锌水平(47.8±10.5μg/ dL)显着低于其他组(LC:68.8±17.1μg/ dL,P = 0.0056,事后检验; LCZ:78.4±18.1, P <0.0001; LCDZ:70.3±21.4,P = 0.0008)。 LCDZ组(548.1±407.6μg/ mg肌酐)的肌酐调节尿锌排泄量显着高于其他组(LC,58.5±43.7; LCZ,208.1±227.8; LCD,105.2±154.4;每个P < 0.0001)。 LCDZ组的尿锌排泄分数也显着高于其他组(LC,0.6±0.5; LCD,1.7±1.5; LCZ,1.6±1.2;每个P <0.0001)。结论:在肝硬化患者中,利尿剂治疗可以通过抑制肾小管对锌的重吸收而增加锌的排泄,这可能导致锌缺乏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号